Green Thumb Amends Brand Licensing Agreements with RYTHM
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 17 hours ago
0mins
Should l Buy RYM?
Source: Newsfilter
- Fee Structure Adjustment: Green Thumb Industries has amended its brand licensing agreements with RYTHM's subsidiaries, transitioning from revenue-based fees to a fixed annual fee of $70 million, which is expected to provide stable cash flow and enhance financial predictability for the company.
- Brand Expansion Commitment: The founder of Green Thumb emphasized the company's dedication to expanding the market reach of RYTHM brands, having successfully built a strong brand presence over the past decade, and will continue to drive long-term growth for these brands.
- Market Positioning Advantage: This agreement amendment not only solidifies Green Thumb's partnership with RYTHM but also enhances its competitive position in the rapidly growing U.S. cannabis consumer goods market, likely attracting more consumers.
- Employee and Market Impact: With approximately 5,000 employees across 14 U.S. markets, the amended agreements will help Green Thumb maintain stable operations and growth in future market expansions, further solidifying its leadership position in the cannabis industry.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy RYM?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on RYM
About RYM
RYTHM, Inc., formerly Agrify Corporation, is a provider of branded innovative solutions for the cannabis and hemp industries. The Company’s portfolio of brands includes RYTHM, incredibles, Dogwalkers, Beboe, Senorita THC Margaritas, & Shine, Doctor Solomon’s and Good Green in thousands of physical locations and online channels. The Company’s portfolio of consumer-packaged goods brands includes Senorita brand which offers consumers hemp-derived tetrahydrocannabinol (THC) beverages that mirror well-known cocktails like a margarita in four flavors, including classic Lime JalapeNo Margarita, Mango Margarita, Paloma and Ranch Water. Senorita offers a low-sugar, low-calorie alternative to alcoholic beverages and is available at retailers, including Total Wine, ABC Fine Wine & Spirits, and Binny’s in 11 U.S. states and Canada. Its comprehensive extraction product line includes hydrocarbon, alcohol, solventless, post-processing, and lab equipment.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Rythm and Green Thumb Amend Licensing Agreement for Long-Term Revenue
- Agreement Revision: Rythm amended its trademark and recipe licensing agreement with Green Thumb, allowing the latter to continue using Rythm's brand portfolio, including incredibles and Beboe, ensuring sustained market competitiveness.
- Fixed Annual Fee: Under the new terms, effective April 1, 2026, Green Thumb will pay Rythm a fixed annual cash fee of $70 million, with annual increases tied to inflation at twice the Consumer Price Index (CPI), providing Rythm with a stable long-term revenue stream.
- Stock Price Surge: Rythm's shares surged nearly 45% on Wednesday, marking the largest intraday gain of 2026 and breaching the 100-day moving average for the first time since December 18, 2025, indicating strong market confidence in its future growth.
- Market Sentiment Shift: Retail sentiment for RYM shifted from 'neutral' to 'extremely bullish', reflecting positive reactions to the new agreement, particularly regarding the anticipated boost in Rythm's gross margins from the royalty fees.
See More
RYTHM Amends Agreements with Green Thumb Industries
- Agreement Revision: RYTHM has amended its trademark and recipe license agreements with a subsidiary of Green Thumb Industries, establishing a fixed annual cash fee of $70 million, subject to yearly increases tied to the consumer price index, indicating a positive outlook for future revenues.
- Brand Usage Rights: The revised agreements cover the use of certain brand intellectual property under existing agreements, ensuring RYTHM can continue leveraging its intellectual property in future brand strategies, thereby enhancing its market competitiveness.
- Effective Date: These amendments will take effect on April 1, 2026, meaning RYTHM will secure a stable cash inflow over the next few years, contributing to its financial stability and long-term growth.
- Market Reaction: RYTHM's stock surged 35.08% in pre-market trading to $24.72, reflecting a positive market response to the agreement revision, which may boost investor confidence in the company's future growth potential.
See More
Green Thumb Amends Brand Licensing Agreements with RYTHM
- Fee Structure Adjustment: Green Thumb Industries has amended its brand licensing agreements with RYTHM's subsidiaries, transitioning from revenue-based fees to a fixed annual fee of $70 million, which is expected to provide stable cash flow and enhance financial predictability for the company.
- Brand Expansion Commitment: The founder of Green Thumb emphasized the company's dedication to expanding the market reach of RYTHM brands, having successfully built a strong brand presence over the past decade, and will continue to drive long-term growth for these brands.
- Market Positioning Advantage: This agreement amendment not only solidifies Green Thumb's partnership with RYTHM but also enhances its competitive position in the rapidly growing U.S. cannabis consumer goods market, likely attracting more consumers.
- Employee and Market Impact: With approximately 5,000 employees across 14 U.S. markets, the amended agreements will help Green Thumb maintain stable operations and growth in future market expansions, further solidifying its leadership position in the cannabis industry.
See More
RYTHM Reports Q4 Financial Results
- Financial Highlights: RYTHM reported a GAAP EPS of -$6.63 for Q4, indicating significant losses; however, revenue surged by 167.5% year-over-year to $10.7 million, showcasing strong momentum in revenue growth.
- Revenue Growth Analysis: The revenue increase was primarily driven by the launch of new products and rising market demand, which not only enhanced the company's market share but also laid the groundwork for future profitability.
- Market Reaction: Despite the substantial revenue growth, the negative EPS may pressure investor confidence, leading to stock price volatility and reflecting market concerns regarding the company's financial health.
- Future Outlook: RYTHM must implement effective measures in upcoming quarters to improve profitability in order to maintain competitiveness in a growing market, especially in light of potential investor skepticism.
See More
Ryman Healthcare (NZSE: RYM) Shares Rise 19% in Quarter, Long-Term Holders Down 81%
- Quarterly Share Price Recovery: Ryman Healthcare's share price increased by 19% in the last quarter; however, long-term holders have faced an 81% decline over the past five years, highlighting a contradiction between short-term gains and long-term value erosion.
- Revenue Growth Analysis: Despite a 13% annual revenue growth rate over the last five years, the company has not been profitable, resulting in a 13% annual stock price decline, reflecting market concerns about its future profitability.
- Shareholder Return Discrepancy: Ryman Healthcare's total shareholder return (TSR) dropped by 77% over the past five years; although the stock price has performed poorly, the impact of reinvested dividends mitigates the decline, indicating the supportive role of dividends.
- Market Performance Comparison: Over the past year, Ryman Healthcare shareholders lost 31%, while the broader market gained 5.6%, indicating the company's performance significantly lags behind the market average, which may affect investor confidence.
See More
What Caused RYTHM (RYM) Stock to Surge More Than 23% Overnight?
Stock Performance: RYTHM Inc. shares rose 23.3% in after-hours trading to $30, despite a 21.52% drop during regular trading, closing at $24.33. The stock has seen a 46.54% decline over the past month.
Q3 Financial Results: The company reported a 98% increase in third-quarter revenue from continuing operations, reaching $4 million, while ending the quarter with $35.6 million in cash despite an $8.9 million operating loss.
Retail Expansion: RYTHM's THC beverage, Señorita THC Margaritas, launched in over 1,000 Circle K stores and select Target locations, marking significant retail expansion for hemp-derived THC products.
Strategic Developments: The company acquired intellectual property for several iconic brands and rebranded from Agrify Corporation to RYTHM Inc., positioning itself to benefit from the growing acceptance of THC beverages among consumers.
See More
Rythm and Green Thumb Amend Licensing Agreement for Long-Term Revenue
- Agreement Revision: Rythm amended its trademark and recipe licensing agreement with Green Thumb, allowing the latter to continue using Rythm's brand portfolio, including incredibles and Beboe, ensuring sustained market competitiveness.
- Fixed Annual Fee: Under the new terms, effective April 1, 2026, Green Thumb will pay Rythm a fixed annual cash fee of $70 million, with annual increases tied to inflation at twice the Consumer Price Index (CPI), providing Rythm with a stable long-term revenue stream.
- Stock Price Surge: Rythm's shares surged nearly 45% on Wednesday, marking the largest intraday gain of 2026 and breaching the 100-day moving average for the first time since December 18, 2025, indicating strong market confidence in its future growth.
- Market Sentiment Shift: Retail sentiment for RYM shifted from 'neutral' to 'extremely bullish', reflecting positive reactions to the new agreement, particularly regarding the anticipated boost in Rythm's gross margins from the royalty fees.
See More
RYTHM Amends Agreements with Green Thumb Industries
- Agreement Revision: RYTHM has amended its trademark and recipe license agreements with a subsidiary of Green Thumb Industries, establishing a fixed annual cash fee of $70 million, subject to yearly increases tied to the consumer price index, indicating a positive outlook for future revenues.
- Brand Usage Rights: The revised agreements cover the use of certain brand intellectual property under existing agreements, ensuring RYTHM can continue leveraging its intellectual property in future brand strategies, thereby enhancing its market competitiveness.
- Effective Date: These amendments will take effect on April 1, 2026, meaning RYTHM will secure a stable cash inflow over the next few years, contributing to its financial stability and long-term growth.
- Market Reaction: RYTHM's stock surged 35.08% in pre-market trading to $24.72, reflecting a positive market response to the agreement revision, which may boost investor confidence in the company's future growth potential.
See More
Green Thumb Amends Brand Licensing Agreements with RYTHM
- Fee Structure Adjustment: Green Thumb Industries has amended its brand licensing agreements with RYTHM's subsidiaries, transitioning from revenue-based fees to a fixed annual fee of $70 million, which is expected to provide stable cash flow and enhance financial predictability for the company.
- Brand Expansion Commitment: The founder of Green Thumb emphasized the company's dedication to expanding the market reach of RYTHM brands, having successfully built a strong brand presence over the past decade, and will continue to drive long-term growth for these brands.
- Market Positioning Advantage: This agreement amendment not only solidifies Green Thumb's partnership with RYTHM but also enhances its competitive position in the rapidly growing U.S. cannabis consumer goods market, likely attracting more consumers.
- Employee and Market Impact: With approximately 5,000 employees across 14 U.S. markets, the amended agreements will help Green Thumb maintain stable operations and growth in future market expansions, further solidifying its leadership position in the cannabis industry.
See More
RYTHM Reports Q4 Financial Results
- Financial Highlights: RYTHM reported a GAAP EPS of -$6.63 for Q4, indicating significant losses; however, revenue surged by 167.5% year-over-year to $10.7 million, showcasing strong momentum in revenue growth.
- Revenue Growth Analysis: The revenue increase was primarily driven by the launch of new products and rising market demand, which not only enhanced the company's market share but also laid the groundwork for future profitability.
- Market Reaction: Despite the substantial revenue growth, the negative EPS may pressure investor confidence, leading to stock price volatility and reflecting market concerns regarding the company's financial health.
- Future Outlook: RYTHM must implement effective measures in upcoming quarters to improve profitability in order to maintain competitiveness in a growing market, especially in light of potential investor skepticism.
See More
Ryman Healthcare (NZSE: RYM) Shares Rise 19% in Quarter, Long-Term Holders Down 81%
- Quarterly Share Price Recovery: Ryman Healthcare's share price increased by 19% in the last quarter; however, long-term holders have faced an 81% decline over the past five years, highlighting a contradiction between short-term gains and long-term value erosion.
- Revenue Growth Analysis: Despite a 13% annual revenue growth rate over the last five years, the company has not been profitable, resulting in a 13% annual stock price decline, reflecting market concerns about its future profitability.
- Shareholder Return Discrepancy: Ryman Healthcare's total shareholder return (TSR) dropped by 77% over the past five years; although the stock price has performed poorly, the impact of reinvested dividends mitigates the decline, indicating the supportive role of dividends.
- Market Performance Comparison: Over the past year, Ryman Healthcare shareholders lost 31%, while the broader market gained 5.6%, indicating the company's performance significantly lags behind the market average, which may affect investor confidence.
See More
What Caused RYTHM (RYM) Stock to Surge More Than 23% Overnight?
Stock Performance: RYTHM Inc. shares rose 23.3% in after-hours trading to $30, despite a 21.52% drop during regular trading, closing at $24.33. The stock has seen a 46.54% decline over the past month.
Q3 Financial Results: The company reported a 98% increase in third-quarter revenue from continuing operations, reaching $4 million, while ending the quarter with $35.6 million in cash despite an $8.9 million operating loss.
Retail Expansion: RYTHM's THC beverage, Señorita THC Margaritas, launched in over 1,000 Circle K stores and select Target locations, marking significant retail expansion for hemp-derived THC products.
Strategic Developments: The company acquired intellectual property for several iconic brands and rebranded from Agrify Corporation to RYTHM Inc., positioning itself to benefit from the growing acceptance of THC beverages among consumers.
See More
